Quest Diagnostics Incorporated (DGX) Financial Analysis and Rating

Comparison Analysis Based on SEC Data

Company Name Quest Diagnostics Incorporated
Industry (SIC) 8071 - Medical Laboratories
Revenue in 2025 $11,035 million (ranked #8 out of 78 companies in the industry)
Assets as of 12/31/2025 $16,225 million (ranked #5)
Market Cap $25,475 million (Oct 9, 2026)
Analyzed report 12/31/2024 (filed 2/20/2025)

Year:
20242025

Financial Position and Performance
Annual | Quarterly

Compared with 2024 industry ratios Change during the year

better
unchanged
Compared with all listed companies

better

Compare with a competitor

Financial Ratios Benchmarking

Financial Ratio Comparison of company ratios for 2024
with industry ratios
(80 - Health Services) 		with all listed companies
Solvency Ratios
Debt ratio 
0.57
0.56
0.57
0.61
Debt-to-equity ratio 
1.36
0.87
1.36
1.35
Interest coverage ratio 
1195.00
-3.87
1195.00
2.45
Liquidity Ratios
Current Ratio 
1.10
1.53
1.10
1.78
Quick Ratio 
0.85
1.29
0.85
1.06
Cash Ratio 
0.25
0.58
0.25
0.59
Profitability Ratios
Profit margin 
8.8%
-1.5%
8.8%
3%
ROE (Return on equity), after tax 
13.2%
2.2%
13.2%
5.1%
ROA (Return on assets) 
5.8%
-2.3%
5.8%
0.9%
Activity Ratios
Asset turnover (days) 
559
488
559
776
Receivables turnover (days) 
47
47
47
48
Resulting score +0,2 +0,6

Year:
20242025

Additional Ratios (not used in score calculation)

Financial Ratio Comparison of company ratios for 2024
with industry ratios
(80 - Health Services) 		with all listed companies
Profitability Ratios
Gross margin 
32.9%
37.4%
32.9%
43.6%
Operating margin (Return on sales) 
12.1%
-2.9%
12.1%
5.1%
Activity Ratios
Inventory turnover (days) 
10
27
10
88
EBIT  $1,195M
EBITDA  $1,688M
Price Ratios
Earnings per Share (basic)  $7.78
Earnings per Share (diluted)